Branded medications like Wegovy and Ozempic are manufactured by Novo Nordisk and are FDA-approved for specific uses
Prescription GLP-1 medications mimic the bodys own GLP-1 hormone, directly activating GLP-1 receptors to produce clinically significant effects, such as appetite suppression, improved insulin response, and weight loss
Current clinical practice considerations emphasize the importance of ophthalmologic screening before initiating GLP-1 therapy in patients with longstanding diabetes and implementing more gradual titration schedules in those with known retinal disease to minimize the risk of early worsening
But when levels of this powerful peptide dip too low, the results can be troubling
By offering Wegovy through both insurance and a straightforward cash-pay option, were giving people more choice, greater transparency, and fewer barriers to care.
It's unclear whether the woman was using Ozempic for weight loss or diabetes treatment, and the duration of her medication use before the bowel injury remains unknown